Special Issues

Special Issue Title: The Role of Surgery in Ovarian Cancer

· Print Special Issue Flyer

· Deadline for manuscript submissions: 30 December 2021

Special Issue Editor

Guest Editor

Chief Consultant Giuseppe Trojano, MD, PhD

Obstetrics and Gynecology Unit, “Madonna delle Grazie” hospital, 75100 Matera, Italy

Website E-Mail

Interests: Cancer; Ovarian Cancer; Cancer Diagnostics; Cancer Biomarkers; Cancer Prevention; Clinical Oncology

Dr. Olga Ostrovsky, PhD

Department of Surgery, Division of Surgical Research, Cooper University Healthcare, Camden, NJ, USA

Website E-Mail

Interests: Tissue Repair by Usage of Adipose-derived Stem Cells; Regulation and Prevention of Ovarian Cancer and Metabolic Diseases by Epigenetic Therapy; Role of Cannabinoids in Post-surgical Tissue Regeneration and Pain Control; Regulatory Check Points of Cell Proliferation; Differentiation and Regrowth

Special Issue Information

Dear Colleagues,

Ovarian cancer is the second most common cause of gynecologic cancer death in women around the world. Primary debulking surgery followed by platinum/taxane-based chemotherapy is the standard of care in advanced EOC. Surgery and platinum‐based chemotherapy are the cornerstones of multimodal treatment in the primary disease setting. The most important prognostic factor for survival is no residual tumour after primary debulking surgery. Two randomised clinical trials comparing Primary debulking surgery and chemotherapy with neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) showed similar survival with a low operative morbidity when NACT and interval debulking surgery were used. The choice between PDS and chemotherapy or NACT and IDS is controversial. Further research is needed on how to select patients for PDS or NACT, including better and validated imaging or laparoscopic scoring systems and algorithms to predict operative morbidity. Systematic pelvic and para-aortic lymphadenectomy in patients with advanced EOC with both intra-abdominal complete resection and clinically negative lymph nodes does not improve overall or progression-free survival. Fertility sparing surgery In young patients with well-differentiated or low-grade, stage IA disease can be considered. Uterus and contralateral ovary can be left in place pending pathology review of the removed tissues and further counseling with the patient.  Selection of patients for fertility preservation requires careful consideration of the risks and benefits. The likelihood of cure is high for women with stage IA disease, but residual disease and subsequent recurrence are associated with low likelihood of salvage.

Dr. Giuseppe Trojano and Dr. Olga Ostrovsky

Guest Editors


Manuscript Submission Information

Manuscripts should be submitted online at https://ejgo.imrpress.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1250. Submitted papers should be well formatted and use good English.


Ovarian Cancer; Primary Debulking Surgery; Fertility Sparing Surgery; Platinum/taxane-based Chemotherapy

Share This Special Issue


Please wait a minute...
For Selected: Toggle Thumbnails

Current Issue

  • Volume 42, Issue 5